{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-027290","form_type":"8-K","ticker":"BMRA","cik":"0000073290","company_name":"BIOMERICA INC","filed_at":"2026-06-04T20:45:41+00:00","discovered_at":"2026-06-04T20:46:02.125384+00:00","generated_at":"2026-06-04T21:11:14.053641+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Biomerica sells Diagnosis stake for $500k to CEO-affiliated buyers; note forgivable on transfer","bullets":["Biomerica sells its 6% stake in Diagnosis S.A. (78,750 shares) to CEO-affiliated entities for $500,000.","CEO Zackary Irani directly acquires $300,000 of the shares; two LLCs buy $200,000 total.","Payments initially made via secured promissory note at 8% interest, due in 12 months; note forgiven upon share transfer.","Transfer requires Polish regulatory approvals expected within 30 days after closing.","Biomerica received $52,000 dividend from Diagnosis in 2026, disclosed to buyers prior to sale."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-027290","json":"https://secwatch.observer/filing/0001493152-26-027290.json","markdown":"https://secwatch.observer/filing/0001493152-26-027290.md","text":"https://secwatch.observer/filing/0001493152-26-027290.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/73290/000149315226027290/0001493152-26-027290-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/73290/000149315226027290/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T21:11:14.053641+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b9bcac5cde8e208c7630a7bf6f0b781d2538e8db","claim":"BIOMERICA INC incurred loan of $500,000 with Buyers affiliated with Zackary Irani, the Company’s Chief Executive Officer at 8% per annum maturing 12 months from the Effective Date.","evidence_excerpt":"the Buyers delivered the Purchase Price in exchange for a secured promissory term note (the “Note”) in the principal amount of $500,000. The Note bears interest at a rate of 8% per annum (the “Stated Interest Rate”) and matures 12 months from the Effective Date","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000149315226027290/0001493152-26-027290-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$500,000"},{"label":"Counterparty","value":"Buyers affiliated with Zackary Irani, the Company’s Chief Executive Officer"},{"label":"Rate","value":"8% per annum"},{"label":"Maturity","value":"12 months from the Effective Date"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}